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ARTICLE
ARE WE BULLETPROOF?:
A DEFENSIVE BUSINESS STRATEGY TO PROTECT
HEALTH CARE COMPANIES FROM FALSE CLAIMS ACT
LITIGATION AND CORPORATE INTEGRITY
AGREEMENTS
By: Jim Moye*
"The days ofscamming dollars from our health care system are
over. Thanks to new tools contained in the Affordable Care Act,
we are more prepared than ever to safeguard taxpayer dollars
and ensure that the health care coverage of our seniors, families
and children is secure.,,[I]

H

ealth care fraud has become a hot topic in corporate America. In
Fiscal Year 2007, an estimated $2.26 trillion was spent on health
care in this country. 2 All governments, but especially the United States
government, stepped up efforts to combat fraud, abuse, and waste in the
health care system. In 2009 alone, the Department of Justice, in
conjunction with other federal agencies, filed 800 indictments, obtained
over 600 convictions, and recouped over $3 billion in health care fraud
cases prosecuted through the False Claims Act. 3 The Federal Bureau of
Investigations claimed it investigated over 2,400 cases of health care

* B.A., 1995, University of Southern California; J.D., 1999, The Catholic University of
America, Columbus School of Law. The author would like to thank Kamina Pinder, Esq.,
Professor, The John Marshall School of Law, for her assistance and support. Additionally, the
author would like to thank Professors George P. Smith, II and Leroy D. Clark (emeritus) of
The Catholic University of America, Columbus School of Law for their guidance and advice
while he was in law school.
Comments and suggestions may be sent to
jim.r.moye@gmail.com.
I
See HHS Secretary Sebilius, u.s. Attorney General Holder Kick Off First Regional
Health Care Fraud Prevention Summit in Miami, Florida, DRUG WK., Aug. 6,2010, at 247,
2010 WLNR 15084270 at 247 (2010).
2 See Beth Fitzgerald, Insurer Sniffs Out Fraud Amid Soaring Health Care Costs, N.J.
BIZ, Sept. 6, 2010, at 5, available at 2010 WLNR 19029436.
3
Press Release, U.S Dep't of Justice, Attorney Gen. Eric Holder speaks at the 2010
BenchlBar Conference in PA, (Sept. 17,2010) available at http://www.justice.gov. ("In
addition, through a new partnership with the Department of Health and Human Services,
we've brought the full resources of the federal government to bear against those who illegally
divert taxpayer resources from government-funded healthcare programs. Last year, the
Department filed more than 800 indictments, and obtained nearly 600 convictions, for health
care fraud-related charges. And, over the past 20 months, the Department has recouped close
to $3 billion in health care fraud cases through use of the False Claims Act.").
24
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fraud in one year. 4 In July 2010, the Department of Justice announced
arguably the largest health care fraud sting in history when it brought
charges against 94 people, located in five different states. 5 The
government charged that the case involved $251 million in Medicare
payments for services that were either medically unnecessary or never
performed. 6 One piece of the case, worth an alleged $70 million, took
place in New York and alleged over 1,000 cash "kickbacks" were paid to
Medicare beneficiaries. 7 The case implicated doctors, health care
company owners, and executives. 8
Another noteworthy case involved AstraZeneca. The pharmaceutical
giant allegedly illegally marketed an anti-psychosis medication for uses
not deemed safe and effective, also known as "off-labeling.,,9 The
settlement agreement signed by the company alleged that marketing the
drug for unapproved purposes caused payment for false claims to
Medicare, Medicaid, TRICARE programs, the Department of Veterans
Affairs, the Federal Employee Health Benefits program, and the Bureau
of Prisons. lo For its perceived transgression, AstraZeneca paid a civil
fine of $520 million and agreed to a second, five-year Corporate Integrity
Agreement with the Department of Health and Human Services. II
Finally, there were lesser allegations that AstraZeneca violated AntiKickback Statutes by making illegal payments to doctors to serve as
authors for studies already completed by AstraZeneca, paying for doctors
to lecture on the unapproved uses of the drug and paying doctors to travel
4
Carrie Johnson, 53 in Detroit and Miami Indicted in Medicare Fraud Sting, WASH.
POST, June 25,2009, at A03.
5 See Jerry Markon, 94 Caught in Major Health-Care Fraud Sting, SEA TILE TIMES, July
17,2010,2010 WLNR 14425674 at A6.
6
!d.
7
Id.
8
[d.
9 Pharmaceutical Giant AstraZeneca to Pay $520 million for Off-Label Drug Marketing
for Regulatory Agencies, BIOTECH WK., May 12, 2010, 2010 WLNR 9382973 at 2506.
Specifically, AstraZeneca allegedly marketed Seroquel for unapproved uses. See id. "Under
the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in
its new drug application to the FDA. Before approving a drug, the FDA must determine that
the drug is safe and effective for the use proposed by the company. Once approved, the drug
may not be marketed or promoted for off-label uses." !d. The allegations also included
"between January 2001 through December 2006, AstraZeneca promoted Seroquel to
psychiatrists and other physicians for certain uses that were not approved by the FDA as safe
and effective (including aggression, Alzheimer's disease, anger management, anxiety,
attention deficit hyperactivity disorder, bipolar maintenance, dementia, depression, mood
disorder, post-traumatic stress disorder, and sleeplessness)." Id.
10
!d.
II
See id. As part of the $520 million settlement the federal government received
$301,907,007 from the civil settlement, state Medicaid programs and the District of Columbia
will share up to $218,092,993 of the civil settlement. See id. Additionally, AstraZeneca was
already under a Corporate Integrity Agreement with the Department of Health and Human
Services. See id.
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to resorts to "advise" AstraZeneca managers on unapproved uses of the
drug. 12
Maryland was rocked by one of the more gruesome tales of health care
fraud. Dr. Mark Midei, considered one of the top cardiologists in
Maryland, served as the Cardiology Department Chairman for the St.
Joseph Medical Center in Towson, Maryland. 13 Dr. Midei joined the
hospital in January 2008 and conducted a number of heart stent
procedures on patients. 14 In fact, between January 2008 and January
2010, when he was relieved of his duties with the hospital, Dr. Midei
performed at least 2,000 separate procedures. IS In late 2009, the hospital
received a complaint from one of Dr. Midei's patients, who also was a
hospital employee. 16 The complaint forced the hospital to review a
sample of Dr. Midei's cases and what they discovered was astounding. 17
After reviewing just under 2,000 of the doctor's case, the hospital
determined that questionable stent placement procedures were conducted
on nearly 600 patients. 18 Further, the hospital discovered that Dr. Midei
had evaded notice during various internal reviews because he was
allowed to submit cases of his choosing for those reviews. 19 In December
2009, the hospital contacted 585 of the impacted patients and informed
them that the stent procedure performed on them may have been
unnecessary.20 In January 2010, the first impacted patient lawsuit was
filed against Dr. Midei and the hospita1. 21 The Maryland state authorities
launched an investigation, leading to newly proposed laws and
12
See id. "The United States also contends that AstraZeneca violated the federal AntiKickback Statute by offering and paying illegal remuneration to doctors it recruited to serve as
authors of articles written by AstraZeneca and its agents about the unapproved uses of
Seroquel. AstraZeneca also offered and paid illegal remuneration to doctors to travel to resort
locations to 'advise' AstraZeneca about marketing messages for unapproved uses of Seroquel,
and paid doctors to give promotional lectures to other health care professionals about
unapproved and unaccepted uses ofSeroquel. The United States contends that these payments
were intended to induce the doctors to prescribe Seroquel for unapproved uses in violation of
the federal Anti-Kickback Statute." Id.
13
Robert Little, Doctor Evaded Peer Review; Cardiologist Accused ofPlacing Unneeded
Stents Also Picked Cases to be Checked, BALT. SUN, May 29, 2010, at AI.
14
See id. A stent is a flexible mesh tube placed in an artery to ensure the artery remains
open. See generally Emily Mullin, More Baltimore-area docs may have implanted
unnecessary stents, lawyer says, BALT. Bus. J., Oct. 5,2010.
15
Little, supra note 13.
16
/d.
17
See id.
18
Id. "After reviewing 'nearly 2,000' of Midei's cases - a number that hospital officials
had not disclosed - reviewers found questionable stents in 585 patients, or about every third or
fourth case." /d.
19
/d.
20 Id.
21
See generally Gary Haber, St. Joseph Medical Center sued Over Stent Implant, BALT.
Bus. J., Jan. 22,2010.
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procedures to combat health care fraud. 22 As of October 2010, 101
individual and single class action lawsuits have been filed in this matter. 23
Finally, the Maryland Board of Physicians charged Dr. Midei with
performing unnecessary medical procedures. 24
Congress also increased its commitment to eradicating health care
fraud. Senator Kristen Gillibrand of New York offered legislation, which
opined that Medicare and Medicaid fraud cost the United States economy
more than $80 billion and the taxpayers of New York more than $5
billion alone?S Spending measures passed by Congress for Fiscal Year
2011 authorized $1.7 billion to combat fraud, waste, and abuse in health
care. 26 An additional $561 million was added late in the budget season to
further bolster these activities. 27
The Office of Inspector General for the United States Department of
Health and Human Services ("OIG") has been busy on these issues as
well. In Fiscal Year 2010, OIG received civil monetary penalties for
twenty-three fraud or fraudulent claims cases and fourteen kickback
cases. 28 These cases resulted in over $19 million in civil monetary
penalties for the OIG in a single year. 29
It is clear that the government significantly raised the stakes for health
care providers participating in Federal health care programs. While the
two examples above are related to large corporations, all entities
submitting claims to Medicare, Medicaid, and other similar programs are
vulnerable to attack. Under such intense scrutiny, how can a health care
provider possibly navigate a new, highly charged environment?

22
Scott Graham, Md. Health Care Chief Calls for Law. Policy Changes in Response to
Stents Query, BALT. Bus. J., Sept. 22, 2010. "John M. Colmers, the secretary of the state's
Department of Health and Mental Hygiene, calls for new laws that would allow Maryland's
health care agencies to share more information with each other, give Maryland's physicians
board greater leeway to investigate complaints against providers and slow the flow of some
information being investigated from being shared with the public." !d.
23
See Mullin, supra note 14.
24 ld.
25
Congo Documents, Gillibrand Announces New Legislation to Reduce and Fraud in
Medicare and Medicaid, Protect Health Care for Seniors, Save Taxpayers Billions (July 13,
2010), available at 2010 WLNR 14089959.
26
Off-Label Marketing Continues as Priority for Federal Fraud Enforcement, FDA Wk.,
Aug. 20, 2010.
27 ld. $376 million would go to the Centers for MedicarelMedicaid Services program
integrity activities, $95 million would go the Office of the Inspector General for Health and
Human Services and $90 million would go to the Department of Justice. See id.
28 See False and Fraudulent Claims, U.S. DEP'T OF HEALTH & HUMAN SERV.: OFFICE OF
INSPECTOR GEN., http://oig.hhs.gov/fraudlenforcementlcmp/false_clairns.asp (last visited Nov.
19,2010); See also Kickback and Physician Self-Referral. U.S. DEP'T OF HEALTH & HUMAN
SERV.: OFFICE OF INSPECTOR GEN., http://oig.hhs.gov/fraudlenforcement/cmp/kickback.asp
(last visited Feb. 2, 2011).
29 See id.
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This Article discusses a systematic approach to building a compliance
program which can survive the aggressive prosecution of health care
fraud. Part I explores the False Claims Act, which is used as the basis to
prosecute health care fraud. 30 Part II considers the Fraud Enforcement
and Recovery Act of 2009, which updated the False Claims Act and is the
basis for intense prosecution. 31 Part III examines Corporate Integrity
Agreements and requirements found in most of those documents. 32
Finally, part IV outlines what a strong compliance program should look
like. 33 Ultimately, this Article concludes that the most effective
compliance program uses the tools already outlined by the federal
government to protect the corporation, its executives, and its
shareholders. 34
1.

THE FALSE CLAIMS ACT

The False Claims Act is the popular title for a series of statutes
restricting fraudulent activity against the federal government. First, the
most commonly known provision of the law makes it illegal to present, or
cause to be presented, fraudulent claims for payment or approval to
federal government employees or members of the military.35 The law
makes it illegal to make, use, or cause to be used false records or
statements material to a fraudulent claim,36 have control or possession of
government money or property and deliver less than the full amount to
the government/ 7 defraud the government by acknowledging receipt of
government property when the property was not received,38 buy or accept
a promise to buy government property from an improper source,39 or
See infra Part I.
See infra Part II.
32
See infra Part III.
33
See infra Part IV.
34
See infra Part V.
35
False Claims Act (Lincoln Law), 31 U.S.C. § 3729(a)(I)(A) (2010) (stating it a federal
crime for any person who "knowingly presents, or causes to be presented, a false or fraudulent
claim for payment or approval. .. ").
36
31 U.S.C. § 3729(a)(l)(8) (stating it is illegal for any person who "knowingly makes,
uses, or causes to be made or used, a false record or statement material to a false or fraudulent
claim ... ").
37
31 U.S.c. § 3729(a)(l)(D) (stating it is unlawful for any person who "has possession,
custody, or control of property or money used, or to be used, by the Government and
knowingly delivers, or causes to be delivered, less than all of that money or property ... ").
38
31 U.S.C. § 3729(a)( I )(E) (stating that the law is violated when a person "is authorized
to make or deliver a document certifying receipt of property used, or to be used, by the
Government and, intending to defraud the Government, makes or delivers the receipt without
completely knowing that the information on the receipt is true ... ").
39
See id. The law creates a prohibition for anyone who "knowingly buys, or receives as
a pledge of an obligation or debt, public property from an officer or employee of the
Government, or a member of the Armed Forces, who lawfully may not sell or pledge property
...." ld.
30

31

29
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commit conspiracy to violate any of the aforementioned provisions. 4o
Any person or entity violating the law was liable for a civil penalty of no
less than $5,000 or no more than $10,000, plus three times the damages
incurred by the government. 41 Interestingly, a provision in the law
allowed the ruling court to reduce the treble damages to double damages
if the person or entity who violated the law notified the government
within 30 days of obtaining the information, the person or entity fully
cooperated with the government investigation, and there was not a
pending legal action already filed. 42
II.

FRAUD ENFORCEMENT AND RECOVERY ACT OF

2009

In response to the financial crisis which began in 2008, Congress
passed the Fraud Enforcement and Recovery Act of 2009 ("FERA,,).43
The law, which passed on May 20, 2009,44 made several changes to
several existing laws. The most substantive overall change amended the
criminal code to define terms related to the mortgage industry, the
Troubled Asset Relief Plan, and the securities industry. 45 The most
important change for the health care industry revolved around two
changes, though. The False Claims Act was amended to expand liability
for making false or fraudulent claims to the federal government 46 and
See id.
See id.
42
See id. The law allows this exception when: "(A) the person committing the violation
of this subsection furnished officials of the United States responsible for investigating false
claims violations with all information known to such person about the violation within 30
days after the date on which the defendant first obtained the information; (B) such person fully
cooperated with any Government investigation of such violation; and (C) at the time such
person furnished the United States with the information about the violation, no criminal
prosecution, civil action, or administrative action had commenced under this title with respect
to such violation, and the person did not have actual knowledge of the existence of an
investigation into such violation." Id.
43
Fraud Enforcement and Recovery Act of 2009, Pub. L. No. 111-21, 123 Stat. 1617 (to
be codified at 31 U.S.C. 3729).
44
Id.
45
See id. Specifically, the law amends the federal criminal code to include within the
defmition of "financial institution" a mortgage lending business or any person or entity that
makes, in whole or in part, a federally related mortgage loan. Next, it defines "mortgage
lending business" as an organization that finances or refinances any debt secured by an
interest in real estate, including private mortgage companies and their subsidiaries, and whose
activities affect interstate or foreign commerce. Third, it extends the prohibition against
making false statements in a mortgage application to employees and agents of a mortgage
lending business. Fourth, applies the prohibition against defrauding the federal government to
fraudulent activities involving the Troubled Asset Relief Program (T ARP) or a federal
economic stimulus, recovery, or rescue plan. Fifth, it expands securities fraud provisions to
cover fraud involving options and futures in commodities. Sixth, it expands the concept of
monetary proceeds, for purposes of enforcing prohibitions against money laundering, to
include gross receipts. See id.
46
See id.
40

41

30
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applied liability for presenting a false or fraudulent claim for payment or
approval to anyone, which were previously limited to just federal
employees and military officers. 47 Another addition now requires persons
who violate the law to reimburse the federal government for the costs of a
civil action to recover penalties or damages. 48 Finally, the new law
expanded the ability of the government to intervene in qui tam actions
brought by whistleblowers against companies defrauding the
government. 49
III.

WHAT IS A CORPORATE INTEGRITY AGREEMENT?

Even if a health care company is successful in evading liability under
the False Claims Act, a Corporate Integrity Agreement ("the Agreement")
may still be necessary to resolve outstanding issues. Corporate Integrity
Agreements are agreements between the OIG and entities that may have
been liable for defrauding the government in federal health care program
transactions such as Medicare and Medicaid. 50 These agreements
generally place nine major requirements on the participant: (1) a
Compliance Committee; (2) internal audit and review processes; (3)
developing and implementing a Code of Conduct; (4) developing and
implementing policies and procedures; (5) developing and implementing
training; (6) retaining an Independent Review Organization; (7)
developing and implementing an Employee Disclosure Program; (8)
screening and removing ineligible persons; (9) and filing incremental
reports. 51 Please note that Corporate Integrity Agreements are intricate
documents containing extensive boilerplate language. This Article takes
a high level view of the standard document and is clear that there may be
unique requirements or language in some documents.

A. Compliance Officer/Compliance Committee
One of the first requirements discussed in a Corporate Integrity
Agreement is a Compliance Committee. First, the Agreement calls for a
defined Compliance Officer position, with specified responsibilities,
47
Compare 31 U.S.C.A. § 3729(a)(1) (2009) ("Any person who knowingly presents, or
causes to be presented, a false or fraudulent claim for payment or approval .... "), with 31
U.S.C.A. § 3729(a)(1) (2008) ("Any person who knowingly presents, or causes to be
presented, to an officer or employee of the United States Government or a member of the
Armed Forces of the United States a false of fraudulent claim for payment or approval .... ").
48 See Fraud Enforcement and Recovery Act § 4(a)(3), 123 Stat. at 1622.
49

50

See id.
Corporate Integrity Agreements, U.S. DEP'T OF HEALTH AND HUMAN SERV., OFFICE OF

INSPECTOR GEN., http://oig.hhs.gov/fraudlcias.asp (last visited Nov. 9,2010).
51
Corporate Integrity Agreement Between the Office of the Inspector General of the
United States Department of Health and Human Services and A&C Health Care Services,
Inc., U.S. DEP'T OF HEALTH AND HUMAN SERV., OFFICE OF INSPECTOR GEN., 1 (Jan. 4,2008),

http://oig.hhs.gov/fraudlcia/agreements/a_c_health_care_services_inc_Ol042008.pdf.
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including: developing and implementing policies and procedures, being a
member of senior management, making reports directly to the Board of
Directors, being authorized to report any issue directly to the Board of
Directors, and requiring superiority over the General Counsel or Chief
Financial Officer. 52 Second, the Agreement calls for the creation of a
Compliance Committee and affirmative action by the Board of Directors,
which may include forming a standing committee or passage of a
reso1ution. 53 Finally, these actions all must be achieved within a stated
timeframe, usually within 120 days of execution of the Agreement. 54
B. Internal Audit and Review Processes

Another major requirement of the Agreement requires signatories to
develop and implement an internal auditing process. 55 Generally, the
internal audit process examines quality of care issues, whether policies
and procedures are followed, and whether training offered to staff and all
obligations of the Agreement are being met. 56 This requirement usually
must be implemented within 90 days. 57
C. Developing and Implementing a Code of Conduct

Third, signatories are required to develop and implement a Code of
Conduct. 58 The Code of Conduct, at a minimum, must reflect the
company's and employees' willingness to comply with federal health
care program requirements; employee obligations and rights under the
Employee Disclosure Program; and consequences of an employee's
failure to report. 59 The Agreement also requires all employees to certify
in writing that they have received, read, understood, and will abide by the

52
See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General
of the United States Department of Health and Human Services and Boston Scientific
Corporation, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUMAN SERVICES, 4-5
(2009), http://oig.hhs.gov/fraud/ciaiagreementlboston_scientific_corporation_12232009 .pdf
(last visited Nov. 8,2010).
53
See id at 5.
54
See id.
55
See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General
for the United States Department of Health and Human Services and Cathedral Rock
Corporation, et. al. , U.S. DEP'T HEALTH AND HUMAN SERV., OFF. OF THE INSPECTOR GEN., 4
(2010), http://oig.hhs.gov/fraud/ciaiagreements/cathedra1Jock_01062010.pdf (last visited
Nov. 8,2010).
56 See id at 4-5.
57
See id at 4.
58 See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General
for the United States Department of Health and Human Services and Interdent, Inc., et. al.,
U.S. DEP'T HEALTH AND HUMAN SERV., OFF. OF THE INSPECTOR GEN., 4 (June 20, 2008),
http://oig.hhs.gov/fraud/ciaiagreements/InterDenUnc_ 06202008.pdf (last visited Nov. 8,
2010).
59 See id at 4-5.
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Code of Conduct. 60 In most Agreements, this requirement must be
implemented within 90 days of execution. 61

D. Develop and Implement Policies and Procedures
Fourth, the Agreement requires the development and implementation
of policies and procedures. 62 These policies and procedures must discuss
the issues covered in the Code of Conduct, the operation of the
company's compliance program, compliance with federal health care
programs, the restriction against hiring or contracting with excluded
persons or entities, and any other issues which initially led to the
Agreement. 63 The required policies and procedures usually must be
implemented within 90 days of execution. 64

E. Develop and Implement Staff Training
Fifth, the Agreement requires the signatories to implement training for
all staff, Executives, and the Board of Directors. 65 The training is split
into two separate categories: General and Specific. 66 Generally, the
General Training is an hour in length and covers the Agreement
requirements, the signatory's Compliance Program, and the issues which
led to the Agreement. 67 General Training must be offered to all staff
including management and the Board of Directors, usually within 90 or
120 days of execution, and requires written certification from each
trainee. 68 Specific Training is technical in nature and for a smaller
universe of employees. 69 Specific Training discusses in-depth federal
health care program issues, relevant policies and procedures, and business

60

6)

Id. at 5.
Id. at 4-5.

62 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between the
Office of the Inspector General for the United States Department of Health and Human
Services and Grant Park Nursing Home Limited Partnership d/b/a Grant Park Care Center
and Grant Park Management, LLC, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND
HUM. SERVICES 5 (2008), http://oig.hhs.gov/fraud/ciaiagreements/grant-park_08292008.pdf
(last visited Feb. 2,2011).
63 Id at 6-8.
64 Id at 5, 9.
65 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office
of Inspector General for the Department of Health and Human Services and Jazz
Pharmaceuticals, Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM.
SERVICES 5 (2007), http://oig.hhs.gov/fraud/ciaiagreements/Jazz%20CIA.pdf (last visited Feb.
2,2011).
66
Id.
68

!d.
!d.

69

Id.

67
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specific issues. 7o Specific Training must be implemented within 90 days
of execution and also requires written certification from each trainee. 71
F. Retain an Independent Review Organization/Monitor
Signatories are required to retain an Independent Review Organization
("IRO,,).72 The IRO must be an accounting, auditing, or consulting firm
and have expertise in billing, coding, reporting, and at least the general
requirements of federal health care programs. 73 The IRO is required to
evaluate and analyze the signatory's coding, billing, federal health care
program claims submission and reimbursements. 74 The evaluation and
analysis exercise is heavily scripted in the Agreement, and at least in the
first year, the IRO must also complete an analysis of whether the
signatory sought certain unallowable costs over the course of the year. 75

G. Develop and Implement an Employee Disclosure Program
A sixth major requirement under the Agreement is for the signatory to
The
develop and implement an Employee Disclosure Program. 76
Employee Disclosure Program is composed of a mechanism to allow an
employee to disclose to someone other than the employee's chain of
command, issues or questions related to potential criminal, civil, or
administrative violations of Medicare or Medicaid statutes and
regulations. 77 The program must develop and implement a policy
emphasizing that employees will not face retaliation or harassment for
disclosing potential violations. 78 Additionally, the program must allow
for anonymous disclosure communications and be implemented generally
within 90 days.79 Finally, the Agreement obligates the Compliance

Id.
See OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES, supra
note 65.
72 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office
ofInspector General for the Department ofHealth and Human Services and Kohal Pharmacy,
Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES 5 (June 21,
http://oig.hhs.gov/fraudlcialagreements/kohat-.Phannacy_inc_06212007.pdf
(last
2007),
visited Feb. 2,2011).
73
Id.
74
Id.
75
Id.
76 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office
of Inspector General for the Department of Health and Human Services and MA. C. T. Health
Board, Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES 5
(2007), http://oig.hhs.gov/fraudiciaiagreementsIMACT_health_board_incI21 72007.pdf (last
visited Feb. 2, 2011).
77
Id.
78
Id.
79
Id.
70

71
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Officer to maintain disclosure logs and make a good faith effort to
investigate all disclosures. 8o
H. Screen and Remove Ineligible Persons

A seventh major requirement in the Agreement centers on ineligible
persons. 8! The Agreement defines ineligible persons as anyone currently
debarred, suspended, or excluded from participating in federal health care
programs or who has a pending conviction for fraud that had not yet
resulted in debarment, suspension, or exclusion. 82 The Agreement
requires the signatory to ensure all employees are not ineligible, that they
are screened against the two federal ineligibility databases, and
implement a policy requiring employees to disclose debarment,
exclusion, or suspension immediately.83 The Agreement finally requires
the removal of any ineligible person from participating in or around
federal health care programs attached to the signatory. 84 In most cases,
this must be implemented within 90 days of execution. 85
IV.

INCREMENTAL REpORTING

The eighth and final major requirement is the submission of
incremental reports. 86 Specifically, the signatory must submit an
Implementation Report within six months of execution that outlines
progress against Agreement obligations to that point. 87 Within 14 months
of execution, an Annual Report must be submitted to the OIG with
specified information and statistics. 88 Subsequently, Annual Reports are
due on the anniversary of the original Annual Report due date. 89

Id.
See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between
Office of Inspector General for the Department of Health and Human Services and McAllen
L.P.
d/b/a
South
Texas
Health
System,
(2009),
Hospitals.
80

81

http://oig.hhs.gov/fraud/cia/agreements/marshaIl_fire"'protection_district_ambulance_and_
rescue_service_03312008.pdf(last visited Feb. 2,2011).
82 Id.
83

Id.

84

Id.atI7.
Id.

85

See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between
Office of Inspector General for the Department of Health and Human Services and Marshall
Fire
Protection
District
Ambulance
and
Rescue
Service,
(2008)
86

http://oig.hhs.gov/cia/agreements/marshaIl_fire"'protection_district_ambulance_and Jescue_
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How CAN A HEALTH CARE COMPANY IMMUNIZE ITSELF IN THIS NEW,
AGGRESSIVE ENVIRONMENT?

Before discussing a defensive strategy, there are two important
assumptions that have to be made. First, how serious is the company
about compliance? Compliance programs take organization, dedication,
and resources. If a company has a half-hearted approach to implementing
compliance efforts and does not provide the necessary supports, it may
create the perception that any questionable behavior was purposeful. The
second assumption is that an organization is not obligated under an
existing settlement agreement with either a public or private entity which
dictates the elements of a compliance program.
It is my belief that utilizing the government's existing response to
health care fraud is the best defense to aggressive prosecution.
Specifically, by dissecting standard Corporate Integrity Agreement
requirements and implementing some provisions in advance as part of an
overall compliance strategy, a health care company can somewhat
immunize itself from fraud allegations and the expense accompanying
investigations and settlements. Further, I believe there are five specific
areas of the Corporate Integrity Agreement that can be the anchor for a
good compliance program: the Compliance Officer, developing and
implementing an Employee Disclosure Program, training, screening
process for ineligible persons, and internal and external audit processes.
A. Hire a Professional Compliance Officer

Virtually every Corporate Integrity Agreement requires a participating
entity to hire a Compliance Officer and/or Compliance Committee. 90
Under the Corporate Integrity Agreement, the Compliance Officer is
responsible for assessing risk, implementing policies and procedures,
monitoring internal and external audits, and reporting to the Executive
Committee, Board of Directors, and Health and Human Services. 91
There are many different position descriptions for a Compliance
Officer. However, ideally, I believe there are six important job
responsibilities. First, the position should have unfettered access to all
aspects of the corporation. Second, the position should review all
policies and procedures and make recommendations for modifications or
improvements.
Third, the position should be responsible for all
investigations and recommendations related to policy and procedure
violations. Fourth, all compliance education and training should be
vested in the position. Fifth, the Compliance Officer should not have any
90
See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreements Document
List, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERV.,
http://oig.hhs.gov/fraud/cialcia_list.asp (last visited Feb. 2, 2011).
91
See supra note 52 and accompanying text.
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duties other than compliance. There is a lengthier discussion on this
subject later in this section. 92 Finally, the position should issue quarterly
reports to the Executive Committee and the Board of Directors on
compliance issues and risk assessments.
Next, who fills the position and to whom do they report? In many
corporations, the Compliance Officer is the General Counselor the Chief
Financial Officer. 93 There are a few problems with another member of
the executive staff undertaking the duties of a Compliance Officer. First,
an executive staff member already has significant responsibilities and
obligations. Managing a compliance program is a full-time job all unto
itself. One issue the government could easily raise in investigating a
Corporate Compliance Program is that the program, as implemented by
the company, is not a priority because it is simply rolled into another
corporate function.
A second, larger issue is a question of independence and objectivity.
Specifically, the General Counsel has an attorney-client relationship with
the corporation and generally serves in an advisory capacity.94 Imagine
that General Counsel advises the corporation against implementing a
policy, which may negatively impact its compliance with federal health
care law. Subsequently, the General Counsel is expected to implement
said policy, measure compliance, and then possibly defend the
corporation in an investigation. Obviously, such a real scenario raises a
number of ethical and legal issues.
The situation does not look more promising for the Chief Financial
Officer. Imagine the Chief Financial Officer implements a financial
policy which negatively impacts the corporation's compliance with
federal health policies and regulations. The corporation lacks an
independent voice to question the legality of the policy implementation.
See infra notes 94-95 and accompanying text.
JONATHAN SMITH & CO., http://www.jonathansmith.comlanne.cfm (last visited Nov. 6,
2010) (Jonathan Smith merges Chief Compliance Officer and Chief Financial Officer);
MEDQUIST, http://www.medquist.com!Default.aspx?tabid=132 (last visited Nov. 6, 2010)
(MedQuist merges Chief Compliance Officer and General Counsel); NAVIGATORS GROUP,
INC., http://www.navg.comlPages/mngmnt-team-detail.aspx?EmpId=102 (last visited Nov. 6,
2010) (Navigators Group merges Chief Compliance Officer and General Counsel); REDWOOD
INVESTMENTS, http://www.redwoodinv.comlRedwood_Investments/Steven_T._Flammey.html
(last visited Feb. 2, 2011) (Redwood Investments merges Chief Compliance Officer and
General Counsel).
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themselves. Cf Upjohn Co. v. U.S., 449 U.S. 383, 389 (1981) (holding that the scope of
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This would raise a red flag for any investigator. Based on those
arguments, the Compliance Officer should be an independent employee.
The next step is to determine the reporting chain for the Compliance
Officer. Based on the previous argument, it does not make legal or
practical sense for the Compliance Officer to report to the General
Counselor the Chief Financial Officer. Most other executive staff
members would have similar conflicts as the General Counselor the
Chief Financial Officer because of their eXIstmg day-to-day
responsibilities. Thus, the best option would be for the position to not be
an executive member of the organization, but report directly to the Chief
Executive Officer and/or the Board of Directors. The Executive
Committee is vested with issues like profitability, which should not be
within the Compliance Officer's scope. Further, a strong argument could
be made that the Compliance Officer should report to the Board of
Directors because they are not involved in the day-to-day management of
the business. Regardless, the Compliance Officer should report to the top
of the corporation's management.
A strongly defined, independent Compliance Officer is evidence that a
corporation takes the compliance function seriously and is the first
element of a strong compliance program. If the Compliance Officer is in
a weakened position, it stands to reason that the program the individual
manages would also be perceived as weak.

B. Develop and Implement an Employee Disclosure Program
Another provision in Corporate Integrity Agreements calls for the
development and implementation of an Employee Disclosure Program. 95
An Employee Disclosure Program is a policy and procedural mechanism
for employees to report what they believe is illegal or immoral behavior
within the organization. 96 These programs also protect employees who
make disclosures against any form of retaliation by the corporation such
as harassment or demotion.
Also, under a Corporate Integrity
Agreement, the Compliance Officer is required to develop and maintain a
log of complaints, which records the complaint, the reporting source, and
the disposition of the complaint. 97 The Compliance Officer also
coordinates the investigation of each complaint.
The reporting
mechanism must be advertised openly and liberally to all employees.
Finally, a list of reporting outlets must be made available to employees,
usually beyond their chain of command. These sources usually include
the Compliance Officer, the State Inspector General, and the OIG.

95

96
97

See supra text accompanying note 76.
See supra text accompanying note 77-79.
See supra text accompanying note 80.
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Developing and implementing an Employee Disclosure Program is a
key component in a corporation's defense strategy. Many qui tam
plaintiffs tell the same story. They observed wrongdoing of some sort in
the workplace and reported it to their supervisor or someone else in their
chain of command. Once they reported it, they were either ignored or
haras~ed for disclosing the acts in question.
While developing such
mechanisms is seemingly uncomfortable for many corporations, the
rationale for such a program is simple. The simple answer is that it may
cost the corporation and may have significant ramifications. If a
corporation has nothing to hide, it would be ideal to have every employee
invested in protecting the corporation from malfeasance. Imagine a
manager in a nursing home had an agreement with a respiratory therapist
whereby the respiratory therapist would submit claims to Medicare, but
would not actually provide service to the patients. The manager agreed to
verify the services as part of the nursing home's treatment plan for its
patients. Imagine further a subordinate discovered the deception and
failed to disclose because the employee feared for his job.
Finally,
consider a patient who actually needed respiratory therapy is denied the
service because of the deceptive agreement between the respiratory
therapist and the manager. The level of liability and risk for the
corporation in the scenario is grave. In any investigation, it will be clear
that the failure to disclose may have been remedied ifthe employee could
have disclosed against the manager.
How would the Employee Disclosure Program be implemented? First,
I would suggest hiring a third party vendor to provide an external 800
telephone number and to actually log disclosures. After logging the
disclosures, the vendor would forward all the relevant information to the
Compliance Officer for investigation and disposition. Utilizing such a
vendor would inspire confidence in the system and ensure the recording
of the information is uncompromised. The Disclosure Program policies
should be clear as to all of the steps of the investigation, report
generation, and disposition of a disclosure. The policy should also
outline the process for ensuring the discloser is protected from any form
of disciplinary action for disclosing. Finally, the policies must be
communicated in a clear and concise manor in every form and medium
available to the corporation. This includes email, open forums, posters,
announcements, and presentations at staff meetings and phone trees. It is
important that all modes of communication are used because a logical
question during a False Claims Act investigation may be how were
employees alerted about the Disclosure Program. The ability to show
constant communication about the Disclosure Program may prove to be
invaluable. If one believes the philosophy that the best defense is a good
defense, the use of a Disclosure Program is a custom made support.
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C. Training
Compliance training for all employees is the next provision in the
strategy.98 As previously noted, Corporate Integrity Agreements require
participants to offer training to all employees. 99 Building a solid
compliance program requires a competent training program.
So, what kind of training is needed? All employees should be trained
on the company's overall compliance program, the False Claims Act,
Employee Disclosure Program, and the consequences of being an
excluded person. Training should be held at least on an annual basis and
also be encompassed in any new employee orientation.
For those employees in claims reimbursement positions, it is critical
that they receive the above-referenced training as well as Medicare and
Medicaid training. Given the intense scrutiny that claim submissions are
receiving from the Centers for Medicare and Medicaid Services, it is
crucial that this training be offered on a quarterly basis. Part of the
strategy articulated in this Article is predicated on building a compliance
program that is risk adverse.
Who should offer the training and how should it be delivered?
Seemingly, there is no need to bring in specialized consultants or trainers.
This Article has advised hiring a professional Compliance Officer, and
that individual can train the staff. Also, it is an excellent opportunity to
acquaint the staff with the Compliance Officer and allow them to ask
questions. As for delivery, there are many available options including
online training. What is most important is that training is offered and
made mandatory for the staff.
D. Screening of Ineligible Persons

Corporate involvement of an ineligible person in a health care
company will inspire investigations by the OIG or the Department of
Justice. As noted above, once a company is under a Corporate Integrity
Agreement, it is restricted from allowing any ineligible individual from
working on behalf of the company in or around federal health care
programs. 100
The company should screen all employees and contractors to ensure
that they are not ineligible persons. Someone who is deemed ineligible
has already been involved in fraud or other malfeasance and could
compromise the company. It is important to note that contractors,
regardless of the service provided on behalf of the company, create as
much risk for the company as an employee and should not be treated any
98
99
100

See supra text accompanying notes 65-71.
See supra text accompanying note 68.
See supra text accompanying notes 81-85.
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differently. These screenings should happen at least on an annual basis
and during the pre-hire process.
In addition, the company should also implement policies which
require all employees and contractors to notify the company if they are
ever served a Notice of Exclusion. Imagine a nurse is employed in a
hospice. While working there, she is implicated in a Medicaid fraud
scheme. Before the matter is settled, the nurse quits her job and takes a
job working in an urgent care clinic. Under the scenario, assume the
urgent care clinic screens all employees for ineligibility during the prehire process and on an annual basis. During her pre-hire process, the
nurse was screened for ineligibility, but was not implicated because the
matter was still pending. Six months after starting her employment with
the urgent care clinic, the matter is resolved and, as a result, the nurse is
served a Notice of Exclusion. If the urgent care clinic did not know the
nurse was excluded, she would continue working, unabated, for six
months until the next round of screenings were conducted. The scenario
merely underscores why the policy is essential.
Also, it is pivotal that regardless of an individual's position within a
company, they must be screened and, if they are found to be ineligible,
removed or activities highly restricted. It is not uncommon for owners or
executives of health care companies to be implicated in malfeasance and
then excluded. 101 These individuals either start companies under new
names or simply move on to another company. \02 Regardless of the
position the individual holds with the company, they are still excluded
and their activities must be carefully managed or the company risks
extreme exposure.
E. Internal and External Audit Processes

The final defensive strategy is to have strong internal and external
audit processes. First, the company should implement a robust internal
audit process. Depending on the company's size, the internal audit
should be conducted at least quarterly and result in a written report
summarizing the audit sample, the findings, and recommendations for
improvements. As described earlier, the Compliance Officer should be
designated coordinator for the audit. Additionally, there should be a
management response to the report which clearly and concisely responds
to the audit's findings.
The external audit process should mirror the internal process and be
conducted on at least an annual basis. Just as with the internal audits, the
external audits should result in a final report which includes a
101
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management response to each finding. While it may seem obvious, the
credentials of the auditing firm must be above reproach. It is important to
note that the credibility of the audit rests on the credibility, independence,
and objectivity of the auditors.
VI.

CONCLUSION

In April 2010, the Maryland General Assembly, in concert with the
Office of the Governor and Maryland Hospital Association, passed the
Maryland False Claims Act ("MFCA,,).103 The act mirrors similar
regulations at the federal level introduced originally by the federal False
Claims Act, which are discussed at length above. I04 With the passage of
MFCA, Maryland has joined several other states in recognizing that
fighting health care fraud at the federal level has its limits, in that only
larger, more global cases are usually prosecuted.10 5 These state acts, like
the MFCA, empower state regulatory agencies with the necessary tools to
fight fraud at a more localized level. I06 The passage of the MFCA is
expected to increase the recovery of Medicaid Funds that were lost to
fraud, waste, or cost recoveries to as much as $46.5 million in fiscal year
2011, an increase of nearly 75% over the current year's estimate of$26.5
million. 107 Beyond granting expressed powers and procedures for state
agencies in prosecuting fraud, the MFCA provides explicit whistleblower
protections to employees and requires employers to conspicuously
provide notice ofthose protections to all employees. 108
The federal government has also made it clear that it intends to
become an aggressive player as it relates to health care fraud. 109 Under
such intense scrutiny, a health care company must take a proactive
approach to protect itself. The keys to developing a protection strategy
can be found in the Corporate Integrity Agreements entered into by
companies and individuals who have run afoul of the Department of
Health and Human Services. There are five particular actions a company
can take to protect itself: hire a professional, independent Compliance
Officer, develop and implement an Employee Disclosure Program,
training, screening for ineligible persons, and internal and external audit
Maryland Register Notice ofSB 279, in April of201O.
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processes. If a health care company shows dedication to a robust
compliance program, it can weather the gathering storm of fraud
prosecution.

